SCHEMBL5010703

SCHEMBL5010703

CN(C)CCN(Cc1ccccc1)S(=O)(=O)c1cccc(Cl)c1Oc1ccccc1C#N

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.46
HTT P42858 2/20 0.44
HTR2A P28223 1/20 0.43
HTR2C P28335 1/20 0.43
SLC6A4 P31645 1/20 0.43
LPAR1 Q92633 1/20 0.38
LPAR5 Q9H1C0 1/20 0.38
TP53 P04637 2/20 0.37
ALDH1A1 P00352 1/20 0.37
PGR P06401 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
TAS2R14 Q9NYV8 1/20 0.36
KCNA5 P22460 1/20 0.36
FNTA P49354 1/20 0.36
FNTB P49356 1/20 0.36
PGGT1B P53609 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5010707 0.82 HSD11B1 (0.60) HSD11B1HTTHTR2AHTR2CSLC6A4
SCHEMBL5012972 0.68 HTR2A (0.53) HTTHTR2AHTR2CSLC6A4TP53
SCHEMBL4822958 0.67 ALDH1A1 (0.49) HTTHTR2AHTR2CSLC6A4ALDH1A1
SCHEMBL533000 0.66 ACLY (0.68) HTTHTR2AHTR2CSLC6A4TP53
SCHEMBL6177741 0.66 AR (0.51)
SCHEMBL5010583 0.66 HTR2A (0.81) HTR2AHTR2CSLC6A4TP53TAS2R14
SCHEMBL5006633 0.65 ALDH1A1 (0.64) HSD11B1HTTHTR2CALDH1A1TAS2R14
SCHEMBL5009435 0.64 ALDH1A1 (0.56) HTTHTR2AHTR2CSLC6A4ALDH1A1
SCHEMBL8296687 0.63 HSD11B1 (1.00) HSD11B1HTTALDH1A1PGR
SCHEMBL4175286 0.63 AR (0.48) SLC6A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008093919-A1 USE OF N-BENZYL-N-(2-DIMETHYLAMINO-ETHYL)BENZENESULFONAMIDE DERIVATIVES FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS DONGBU HITEK CO., LTD. (KR) 2008-08-07 WO claimed
WO-2008093919-A1 USE OF N-BENZYL-N-(2-DIMETHYLAMINO-ETHYL)BENZENESULFONAMIDE DERIVATIVES FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS DONGBU HITEK CO., LTD. (KR) 2008-08-07 WO disclosed